nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—CYP1A2—Thalidomide—leprosy	0.307	0.508	CbGbCtD
Pentoxifylline—CYP1A2—Rifampicin—leprosy	0.298	0.492	CbGbCtD
Pentoxifylline—ADORA1—nerve—leprosy	0.0202	0.114	CbGeAlD
Pentoxifylline—Leukaemia—Thalidomide—leprosy	0.0192	0.0883	CcSEcCtD
Pentoxifylline—PDE5A—blood vessel—leprosy	0.0168	0.0942	CbGeAlD
Pentoxifylline—NT5E—eye—leprosy	0.0138	0.0772	CbGeAlD
Pentoxifylline—NT5E—skin of body—leprosy	0.012	0.0672	CbGeAlD
Pentoxifylline—ADORA2B—eye—leprosy	0.0118	0.0661	CbGeAlD
Pentoxifylline—NT5E—tendon—leprosy	0.00911	0.0512	CbGeAlD
Pentoxifylline—PDE5A—eye—leprosy	0.00893	0.0501	CbGeAlD
Pentoxifylline—NT5E—testis—leprosy	0.00754	0.0424	CbGeAlD
Pentoxifylline—NT5E—nervous system—leprosy	0.0074	0.0416	CbGeAlD
Pentoxifylline—Cholestasis—Thalidomide—leprosy	0.0068	0.0313	CcSEcCtD
Pentoxifylline—ADORA2B—testis—leprosy	0.00646	0.0363	CbGeAlD
Pentoxifylline—ADORA2B—nervous system—leprosy	0.00634	0.0356	CbGeAlD
Pentoxifylline—PDE5A—tendon—leprosy	0.00591	0.0332	CbGeAlD
Pentoxifylline—PDE4A—testis—leprosy	0.00576	0.0323	CbGeAlD
Pentoxifylline—ADORA1—tendon—leprosy	0.0056	0.0315	CbGeAlD
Pentoxifylline—ADORA2A—testis—leprosy	0.00537	0.0302	CbGeAlD
Pentoxifylline—ADORA2A—nervous system—leprosy	0.00527	0.0296	CbGeAlD
Pentoxifylline—Eructation—Thalidomide—leprosy	0.00507	0.0234	CcSEcCtD
Pentoxifylline—PDE5A—testis—leprosy	0.00489	0.0275	CbGeAlD
Pentoxifylline—Aplastic anaemia—Thalidomide—leprosy	0.00485	0.0223	CcSEcCtD
Pentoxifylline—PDE5A—nervous system—leprosy	0.0048	0.027	CbGeAlD
Pentoxifylline—Cramps of lower extremities—Thalidomide—leprosy	0.00474	0.0219	CcSEcCtD
Pentoxifylline—ADORA1—testis—leprosy	0.00464	0.0261	CbGeAlD
Pentoxifylline—Lightheadedness—Thalidomide—leprosy	0.00462	0.0213	CcSEcCtD
Pentoxifylline—ADORA1—nervous system—leprosy	0.00455	0.0256	CbGeAlD
Pentoxifylline—Erythema—Dapsone—leprosy	0.00441	0.0203	CcSEcCtD
Pentoxifylline—Vascular purpura—Thalidomide—leprosy	0.00419	0.0193	CcSEcCtD
Pentoxifylline—Vision blurred—Dapsone—leprosy	0.00415	0.0191	CcSEcCtD
Pentoxifylline—PDE4B—tendon—leprosy	0.00414	0.0233	CbGeAlD
Pentoxifylline—Purpura—Thalidomide—leprosy	0.00389	0.0179	CcSEcCtD
Pentoxifylline—Tachycardia—Dapsone—leprosy	0.00351	0.0162	CcSEcCtD
Pentoxifylline—PDE4B—testis—leprosy	0.00343	0.0193	CbGeAlD
Pentoxifylline—PDE4B—nervous system—leprosy	0.00337	0.0189	CbGeAlD
Pentoxifylline—Abdominal distension—Thalidomide—leprosy	0.00326	0.015	CcSEcCtD
Pentoxifylline—Insomnia—Dapsone—leprosy	0.00325	0.015	CcSEcCtD
Pentoxifylline—Bronchospasm—Thalidomide—leprosy	0.00319	0.0147	CcSEcCtD
Pentoxifylline—Angina pectoris—Thalidomide—leprosy	0.00315	0.0145	CcSEcCtD
Pentoxifylline—Pancytopenia—Thalidomide—leprosy	0.00308	0.0142	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Dapsone—leprosy	0.00294	0.0136	CcSEcCtD
Pentoxifylline—Infestation—Thalidomide—leprosy	0.00289	0.0133	CcSEcCtD
Pentoxifylline—Drowsiness—Thalidomide—leprosy	0.00289	0.0133	CcSEcCtD
Pentoxifylline—Infestation NOS—Thalidomide—leprosy	0.00289	0.0133	CcSEcCtD
Pentoxifylline—Abdominal pain—Dapsone—leprosy	0.00284	0.0131	CcSEcCtD
Pentoxifylline—Body temperature increased—Dapsone—leprosy	0.00284	0.0131	CcSEcCtD
Pentoxifylline—Conjunctivitis—Thalidomide—leprosy	0.00281	0.0129	CcSEcCtD
Pentoxifylline—Sweating—Thalidomide—leprosy	0.00277	0.0128	CcSEcCtD
Pentoxifylline—Epistaxis—Thalidomide—leprosy	0.00272	0.0126	CcSEcCtD
Pentoxifylline—Hepatitis—Thalidomide—leprosy	0.00259	0.0119	CcSEcCtD
Pentoxifylline—Immune system disorder—Thalidomide—leprosy	0.00234	0.0108	CcSEcCtD
Pentoxifylline—Arrhythmia—Thalidomide—leprosy	0.00232	0.0107	CcSEcCtD
Pentoxifylline—Vomiting—Dapsone—leprosy	0.00229	0.0105	CcSEcCtD
Pentoxifylline—Headache—Dapsone—leprosy	0.00225	0.0104	CcSEcCtD
Pentoxifylline—Flatulence—Thalidomide—leprosy	0.00222	0.0102	CcSEcCtD
Pentoxifylline—Tension—Thalidomide—leprosy	0.00221	0.0102	CcSEcCtD
Pentoxifylline—Dysgeusia—Thalidomide—leprosy	0.00221	0.0102	CcSEcCtD
Pentoxifylline—Nervousness—Thalidomide—leprosy	0.00219	0.0101	CcSEcCtD
Pentoxifylline—Back pain—Thalidomide—leprosy	0.00218	0.0101	CcSEcCtD
Pentoxifylline—Muscle spasms—Thalidomide—leprosy	0.00217	0.01	CcSEcCtD
Pentoxifylline—Nausea—Dapsone—leprosy	0.00214	0.00985	CcSEcCtD
Pentoxifylline—Vision blurred—Thalidomide—leprosy	0.00213	0.0098	CcSEcCtD
Pentoxifylline—Tremor—Thalidomide—leprosy	0.00211	0.00974	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Thalidomide—leprosy	0.00209	0.00965	CcSEcCtD
Pentoxifylline—Anaemia—Thalidomide—leprosy	0.00209	0.00961	CcSEcCtD
Pentoxifylline—Agitation—Thalidomide—leprosy	0.00207	0.00956	CcSEcCtD
Pentoxifylline—Angioedema—Thalidomide—leprosy	0.00206	0.0095	CcSEcCtD
Pentoxifylline—Malaise—Thalidomide—leprosy	0.00204	0.00938	CcSEcCtD
Pentoxifylline—Leukopenia—Thalidomide—leprosy	0.00202	0.00931	CcSEcCtD
Pentoxifylline—Palpitations—Thalidomide—leprosy	0.00199	0.00919	CcSEcCtD
Pentoxifylline—Convulsion—Thalidomide—leprosy	0.00196	0.00901	CcSEcCtD
Pentoxifylline—Hypertension—Thalidomide—leprosy	0.00195	0.00898	CcSEcCtD
Pentoxifylline—Chest pain—Thalidomide—leprosy	0.00192	0.00885	CcSEcCtD
Pentoxifylline—Myalgia—Thalidomide—leprosy	0.00192	0.00885	CcSEcCtD
Pentoxifylline—Anxiety—Thalidomide—leprosy	0.00191	0.00882	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00191	0.00879	CcSEcCtD
Pentoxifylline—Discomfort—Thalidomide—leprosy	0.0019	0.00875	CcSEcCtD
Pentoxifylline—Dry mouth—Thalidomide—leprosy	0.00188	0.00866	CcSEcCtD
Pentoxifylline—Confusional state—Thalidomide—leprosy	0.00186	0.00856	CcSEcCtD
Pentoxifylline—Oedema—Thalidomide—leprosy	0.00184	0.00849	CcSEcCtD
Pentoxifylline—Infection—Thalidomide—leprosy	0.00183	0.00843	CcSEcCtD
Pentoxifylline—Shock—Thalidomide—leprosy	0.00181	0.00835	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Thalidomide—leprosy	0.0018	0.00831	CcSEcCtD
Pentoxifylline—Tachycardia—Thalidomide—leprosy	0.0018	0.00828	CcSEcCtD
Pentoxifylline—Skin disorder—Thalidomide—leprosy	0.00179	0.00824	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Thalidomide—leprosy	0.00178	0.00821	CcSEcCtD
Pentoxifylline—Anorexia—Thalidomide—leprosy	0.00176	0.00809	CcSEcCtD
Pentoxifylline—Hypotension—Thalidomide—leprosy	0.00172	0.00793	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Thalidomide—leprosy	0.00168	0.00773	CcSEcCtD
Pentoxifylline—Insomnia—Thalidomide—leprosy	0.00167	0.00768	CcSEcCtD
Pentoxifylline—Dyspnoea—Thalidomide—leprosy	0.00164	0.00757	CcSEcCtD
Pentoxifylline—Somnolence—Thalidomide—leprosy	0.00164	0.00755	CcSEcCtD
Pentoxifylline—Dyspepsia—Thalidomide—leprosy	0.00162	0.00747	CcSEcCtD
Pentoxifylline—Decreased appetite—Thalidomide—leprosy	0.0016	0.00738	CcSEcCtD
Pentoxifylline—Constipation—Thalidomide—leprosy	0.00157	0.00726	CcSEcCtD
Pentoxifylline—Feeling abnormal—Thalidomide—leprosy	0.00152	0.00699	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Thalidomide—leprosy	0.00151	0.00694	CcSEcCtD
Pentoxifylline—Urticaria—Thalidomide—leprosy	0.00146	0.00674	CcSEcCtD
Pentoxifylline—Abdominal pain—Thalidomide—leprosy	0.00146	0.00671	CcSEcCtD
Pentoxifylline—Body temperature increased—Thalidomide—leprosy	0.00146	0.00671	CcSEcCtD
Pentoxifylline—Hypersensitivity—Thalidomide—leprosy	0.00136	0.00625	CcSEcCtD
Pentoxifylline—Asthenia—Thalidomide—leprosy	0.00132	0.00609	CcSEcCtD
Pentoxifylline—Pruritus—Thalidomide—leprosy	0.0013	0.00601	CcSEcCtD
Pentoxifylline—Diarrhoea—Thalidomide—leprosy	0.00126	0.00581	CcSEcCtD
Pentoxifylline—Dizziness—Thalidomide—leprosy	0.00122	0.00561	CcSEcCtD
Pentoxifylline—Vomiting—Thalidomide—leprosy	0.00117	0.0054	CcSEcCtD
Pentoxifylline—Rash—Thalidomide—leprosy	0.00116	0.00535	CcSEcCtD
Pentoxifylline—Dermatitis—Thalidomide—leprosy	0.00116	0.00535	CcSEcCtD
Pentoxifylline—Headache—Thalidomide—leprosy	0.00115	0.00532	CcSEcCtD
Pentoxifylline—Nausea—Thalidomide—leprosy	0.00109	0.00504	CcSEcCtD
